V5 Ultimate
Ultimate
PricingResourcesCompany
Start free trial
Playbook · FDA inspections

FDA Form 483 and Warning Letter Response: 15-Day Timeline, Root-Cause Discipline and CAPA Closure

Respond to each observation with root cause, corrections, dated systemic actions and checks. A response within 15 business days is generally reviewed first.

3 min readFor quality, regulatory and executive leads at FDA-regulated drug, device, supplement and food manufacturers responding to FDA inspection observations and Warning Letters
Auditor and quality lead in full protective clothing reviewing records on a tablet on the production floor

In short

  1. 1Aim to respond within 15 business days.
  2. 2Fix the system, not only the example.
  3. 3Track every commitment with evidence.
Guide page 6: out-of-spec result to investigation to CAPA, with effectiveness criteria examplesGuide page 4: eight-stage map from issue raised to human closure, with evidence and owner at each stageCover of Quality Management Buyer Guide by V5 Ultimate
Free guide

Quality Management Buyer Guide

For quality, regulatory and operations teams choosing quality management software. Use it with or without V5.

12 pages

Inside
  • Map every issue from raised to human closure.
  • Set CAPA effectiveness criteria before you act.
  • Separate regulation, configured workflow and lab features.
Get the quality management guide

Free. Just your name and email, and it downloads instantly.

We use your details to handle this request. Privacy policy. Practical orientation, not legal advice; your quality unit decides which rules apply.

Contents
  1. The 15-business-day window
  2. What a credible response contains
  3. Root cause and CAPA
  4. Warning Letters and commitments
  5. Ready for re-inspection
  6. Questions
Contents
  1. The 15-business-day window
  2. What a credible response contains
  3. Root cause and CAPA
  4. Warning Letters and commitments
  5. Ready for re-inspection
  6. Questions

A Form 483 lists observations an FDA investigator made at the end of an inspection. FDA expects firms to respond in writing with a corrective action plan and carry it out promptly. Under a 2009 notice, a response received within 15 business days is generally reviewed in detail before FDA decides on a Warning Letter. Sources checked 3 Oct 2026.

01

The 15-business-day window

FDA's notice Review of Post-Inspection Responses (74 FR 40211, 11 Aug 2009) says FDA will generally allow 15 business days for a response to 483 observations before issuing a Warning Letter, and will not ordinarily delay a Warning Letter to review a later response. A 483 is not an exhaustive list of every problem, so look for related conditions as well.

From close-out to response

  1. Day 0
    Observations read and discussed at the close-out meeting
    FDA and management
  2. Days 1–5
    Investigation, containment and root cause started
    Quality
  3. Days 6–12
    Corrective actions, owners and dates agreed; evidence gathered
    Owners
  4. Within 15 business days
    Written response sent
    Senior management
74 FR 40211. Internal steps are an example.
02

What a credible response contains

Address each observation: what you found, the root cause, corrections already made, systemic actions with dates and owners, and how you will check they worked. Include evidence where you have it and avoid commitments you cannot keep.

For each observation

0 of 5 in place
03

Root cause and CAPA

Look past the cited example to the system that allowed it, such as procedures, training, design of the record or oversight. Check whether the same cause affects other products, lines or sites, and define effectiveness checks before you close the CAPA.

04

Warning Letters and commitments

A Warning Letter usually asks for a written reply within a stated time. Senior management should own the response.

More on warning Letters and commitments

Track every commitment with owner, due date and evidence, and report progress as promised.

05

Ready for re-inspection

Before FDA returns, confirm each commitment is complete, evidenced and effective, and that staff can explain the changes. Review records created since the inspection for the same weaknesses.

How V5 supports this

V5 keeps CAPA, deviations, change control, documents and training with owners and due dates. Your team writes the response and decides actions.

  • Document controlVersioned SOPs with review and e-signatures.
  • QMSCAPA, deviations and change control linked together.
  • Audits & CAPAFindings routed to owners with due dates.

Questions

Is a 483 response legally required?

FDA expects a written response with a corrective action plan; a response within 15 business days is generally reviewed before a Warning Letter decision (74 FR 40211).

Is a 483 a final agency finding?

No. It lists investigator observations; FDA decides on any further action after review.

Should we only fix the cited examples?

No. FDA's FAQ notes firms are responsible for related non-cited conditions too.

What does V5 provide?

CAPA, deviations, change control, document control and training records with owners and due dates. Your team writes the response and decides actions.

Practical orientation, not legal advice. Rules differ by jurisdiction; your quality and compliance team decides what applies.

Keep reading

  • Product Recall Response Timeline and Coordination Playbook
  • Sports Nutrition Dosage Forms: Protein, EAA and Creatine
  • ASEAN Supplement Rules: BPOM, Thai FDA, Vietnam and PH FDA
  • California Prop 65 Warnings: Labels, Short Form, Online Sales and Supplier Notices
  • DHR vs eDHR: What FDA Requires After QMSR
  • 21 CFR 106 Infant Formula CGMP Guide: Release, Testing and Traceability
All guides
V5 Ultimate
Ultimate

Warehouse, quality and manufacturing software for regulated operations.

ProductIndustriesPricingResourcesSecurity & TrustCompanyLegal centre

© V5 Ultimate

Page version 1.2 · Last revised 3 Oct 2026